1. Home
  2. ONMD vs CRIS Comparison

ONMD vs CRIS Comparison

Compare ONMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.76

Market Cap

34.7M

Sector

N/A

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.89

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
CRIS
Founded
2006
2000
Country
United States
United States
Employees
22
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
14.0M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ONMD
CRIS
Price
$0.76
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
9.4M
109.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$9,898,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
$7.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.50
52 Week Low
$0.30
$0.77
52 Week High
$4.22
$3.13

Technical Indicators

Market Signals
Indicator
ONMD
CRIS
Relative Strength Index (RSI) 51.82 38.44
Support Level $0.60 $0.80
Resistance Level $0.91 $1.04
Average True Range (ATR) 0.12 0.07
MACD 0.02 -0.02
Stochastic Oscillator 24.60 17.86

Price Performance

Historical Comparison
ONMD
CRIS

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: